Synthesis of carbon-14 and deuterium labeled 3-isobutyryl-2-isopro-pylpyrazolo [1, 5-a]pyridine
✍ Scribed by Yoshio Nagatsu; Koichi Takagi
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- French
- Weight
- 305 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
In order to study the metabolic fate of 3-isobutyryl-2-isopropylpyrazolo~1,5-aJpyridine [I, in experimental animals and humans, the synthesis of I labeled with carbon-14 or deuterium was investiqated. Carbon-14 labeled I was obtained from 5 mCi of isobutyric acid-l-14C sodium salt with a 6 7 . 7 % yield. Its specific activity was 2 4 . 7 pCi/mg. with a 1 7 . 0 % yield, which resulted in about 50% replacement of deuterium with hydrogen at the position 7 in I. The release of deuterium apparently did not occur on GC-MS.
The mixture of deuterium labeled I and unlabeled I (2:l mole ratio) supplied nearly the same intensity of triplet ions (ion clusters) used for identification of I and its metabolites.
Deuterium labeled I was synthesized from pyridine-d5
📜 SIMILAR VOLUMES
## Abstract Methods of preparation of carbon‐14 and deuterium labeled N‐nitroso‐2(3′,7′‐dimethyl‐2′,6′‐octadienyl)aminoethanols are described. The primary synthetic method involved alkylation of ethanolamine or ethylglycine with suitable chlorides and subsequent mild nitrosation. Isomeric ^14^C‐nit
## Abstract The preparation of pure octahydro‐1,3,5,7‐tetranitro‐1,3,5,7‐tetrazocine (HMX) labelled with nitrogen‐15 and deuterium was accomplished by sequential nitrolysis of appropriately labelled octahydro‐1,5‐diacetyl‐3,7‐endomethylene‐1,3,5,7‐tetrazocine. The latter compounds were obtained fro
## Abstract Carbon‐13 and carbon‐14 labeled forms of the title compound have been prepared from the correspondingly labeled forms of 8‐chloro‐1‐methyl‐6‐phenyl‐4H‐__s__‐triazolo[4,3‐a][1,4]benzodiazepine (__3__)Alprazolam is the generic USAN name for this compound. . A modified and more convenient
## Abstract 5‐Methoxy‐2‐methyl‐1‐(3,4‐methylenedioxybenzoyl)indole‐3‐acetic acid (ID‐955)(I), a new anti‐inflammatory agent, was labelled with carbon‐14 at C‐2 position of indole nucleus for the use of metabolic studies. The procedure used is shown in Fig. 1 and 2. Levulinic‐4‐^14^C acid was synthe